Innate resistance to herpes simplex virus infection. Human lymphocyte and monocyte inhibition of viral replication
- PMID: 2155270
Innate resistance to herpes simplex virus infection. Human lymphocyte and monocyte inhibition of viral replication
Abstract
Peripheral blood monocytes and lymphocytes isolated from most humans are resistant to HSV infection in vitro. Viral replication is inhibited very early in the cycle, prior to the onset of alpha-protein synthesis; no viral protein or DNA synthesis is detectable even up to 1 week later. The enhanced expression of two 62-kDa and 57-kDa cellular proteins, however, is induced in the lymphocyte population within 3 to 5 h after infection. A 30-kDa protein is induced in the monocyte population immediately after infection. The induced expression of 62-kDa and 57-kDa lymphocyte proteins appears to be virus-mediated because: a) HSV and pseudorabies virus (although not vaccinia virus) induce the expression of 62-kDa and 57-kDa proteins, b) heat shock or exposure of lymphocytes to uninfected cell extracts does not induce expression of either protein, c) 62-kDa protein is not induced in lymphocytes stimulated with a mitogenic concentration of PHA. UV-inactivated HSV induces expression of 62-kDa and 57-kDa proteins in a manner similar to that observed with untreated virus. In contrast, expression of 30-kDa monocyte protein is induced nonspecifically by either uninfected cell extracts or cell extracts containing virus. Sixty-two-kilodalton and 57-kDa protein induction appears to be a marker for human lymphocytes that express profound intracellular resistance to infection with HSV. Induced expression of these proteins occurs only in lymphocytes that inhibit viral replication very early in the growth cycle, prior to the onset of alpha-protein synthesis. Expression of 62-kDa and 57-kDa proteins is not induced in lymphocytes that are permissive or partially permissive to infection with HSV.
Similar articles
-
Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication.J Immunol. 1988 Oct 15;141(8):2740-8. J Immunol. 1988. PMID: 2844905
-
Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.J Immunol. 1984 Feb;132(2):914-9. J Immunol. 1984. PMID: 6317753
-
T lymphocytes activated by interleukin 2 alone acquire permissiveness for replication of herpes simplex virus.Eur J Immunol. 1986 Jun;16(6):709-11. doi: 10.1002/eji.1830160620. Eur J Immunol. 1986. PMID: 3013641
-
Effects of varicella zoster virus or herpes simplex virus type I infection in vitro on response of human peripheral blood mononuclear cells to phytohemagglutinin.Acta Med Okayama. 1995 Dec;49(6):309-12. doi: 10.18926/AMO/30381. Acta Med Okayama. 1995. PMID: 8770240 Review.
-
Virus infections of lympho-reticular cells and auto-immune diseases.Transplant Rev. 1976;31:79-115. Transplant Rev. 1976. PMID: 785732 Review. No abstract available.
Cited by
-
Inclusion of CD80 in HSV targets the recombinant virus to PD-L1 on DCs and allows productive infection and robust immune responses.PLoS One. 2014 Jan 27;9(1):e87617. doi: 10.1371/journal.pone.0087617. eCollection 2014. PLoS One. 2014. PMID: 24475315 Free PMC article.
-
Lymphoid-related CD11c+ CD8alpha+ dendritic cells are involved in enhancing herpes simplex virus type 1 latency.J Virol. 2008 Oct;82(20):9870-9. doi: 10.1128/JVI.00566-08. Epub 2008 Jul 30. J Virol. 2008. PMID: 18667491 Free PMC article.
-
A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages.Virol J. 2009 May 13;6:56. doi: 10.1186/1743-422X-6-56. Virol J. 2009. PMID: 19439086 Free PMC article.
-
Essential role of M1 macrophages in blocking cytokine storm and pathology associated with murine HSV-1 infection.PLoS Pathog. 2021 Oct 15;17(10):e1009999. doi: 10.1371/journal.ppat.1009999. eCollection 2021 Oct. PLoS Pathog. 2021. PMID: 34653236 Free PMC article.
-
Unravelling the first key steps in equine herpesvirus type 5 (EHV5) pathogenesis using ex vivo and in vitro equine models.Vet Res. 2019 Feb 18;50(1):13. doi: 10.1186/s13567-019-0630-6. Vet Res. 2019. PMID: 30777128 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical